A Study to Evaluate the Relative Bioavailability of Formulations of CKD-510 and to Assess the Effect of Food on the CKD-510 Tablet Formulation in Healthy Subjects
Clinical trial NCT05526742 · COMPLETED
Trial details
- NCT number
- NCT05526742
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-24
- Primary completion
- 2022-09-13
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.